Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38,539,454
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
4,558,729
-
Shares change
-
+120,758
-
Total reported value, excl. options
-
$4,832,638
-
Value change
-
+$119,650
-
Put/Call ratio
-
102%
-
Number of buys
-
14
-
Number of sells
-
-16
-
Price
-
$1.06
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q3 2023
53 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q3 2023.
Co-Diagnostics, Inc. - Common Stock (CODX) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,558,729 shares
of 38,539,454 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,781,283 shares), RENAISSANCE TECHNOLOGIES LLC (636,400 shares), BlackRock Inc. (502,708 shares), GEODE CAPITAL MANAGEMENT, LLC (294,422 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (272,900 shares), Bank of New York Mellon Corp (145,621 shares), Kestra Advisory Services, LLC (128,560 shares), Koss-Olinger Consulting, LLC (111,808 shares), STATE STREET CORP (100,647 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (81,285 shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.